BONUSCAP-ZERTIFIKAT - PFIZER INC Stock

Certificat

DE000HD41NM6

Market Closed - Boerse Frankfurt Warrants 13:29:26 2024-06-14 EDT
34.47 EUR -0.38% Intraday chart for BONUSCAP-ZERTIFIKAT - PFIZER INC
Current month-0.40%
1 month-0.52%
Date Price Change
24-06-14 34.47 -0.38%
24-06-13 34.6 +0.12%
24-06-12 34.56 -0.29%
24-06-11 34.66 -0.09%
24-06-10 34.69 -0.91%

Real-time Boerse Frankfurt Warrants

Last update June 14, 2024 at 01:29 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD41NM
ISINDE000HD41NM6
Date issued 2024-03-22
Strike 37 $
Maturity 2025-03-21 (279 Days)
Parity 1 : 1
Emission price 34.39
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 35.07
Lowest since issue 31.2
Spread 0.01
Spread %0.03%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.53 USD
Average target price
31.92 USD
Spread / Average Target
+15.93%
Consensus